1. Home
  2. RLMD vs PRE Comparison

RLMD vs PRE Comparison

Compare RLMD & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

319.7M

Sector

Health Care

ML Signal

HOLD

Logo Prenetics Global Limited

PRE

Prenetics Global Limited

HOLD

Current Price

$15.66

Market Cap

369.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLMD
PRE
Founded
2004
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
319.7M
369.7M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
RLMD
PRE
Price
$4.08
$15.66
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$9.00
$32.00
AVG Volume (30 Days)
620.1K
281.8K
Earning Date
03-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
19.21
N/A
EPS
N/A
N/A
Revenue
$13,070.00
N/A
Revenue This Year
N/A
$110.85
Revenue Next Year
N/A
$64.36
P/E Ratio
N/A
N/A
Revenue Growth
154.83
N/A
52 Week Low
$0.24
$3.09
52 Week High
$5.12
$22.86

Technical Indicators

Market Signals
Indicator
RLMD
PRE
Relative Strength Index (RSI) 52.15 36.58
Support Level $3.81 $12.71
Resistance Level $4.56 $16.81
Average True Range (ATR) 0.35 2.03
MACD 0.04 -0.58
Stochastic Oscillator 68.39 10.34

Price Performance

Historical Comparison
RLMD
PRE

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.

Share on Social Networks: